Статті в журналах з теми "Antineoplastic agents"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Antineoplastic agents".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Carlson, Patricia A. "Antineoplastic agents." Critical Care Nursing Quarterly 18, no. 4 (February 1996): 1–15. http://dx.doi.org/10.1097/00002727-199602000-00002.
Menta, Ernesto, and Manlio Palumbo. "Novel antineoplastic agents." Expert Opinion on Therapeutic Patents 7, no. 12 (December 1997): 1401–26. http://dx.doi.org/10.1517/13543776.7.12.1401.
Menta, Ernesto, and Manlio Palumbo. "Antineoplastic agents 1998." Expert Opinion on Therapeutic Patents 8, no. 12 (December 1998): 1627–72. http://dx.doi.org/10.1517/13543776.8.12.1627.
Pettit, G. R., Y. Kamano, R. Aoyagi, C. L. Herald, D. L. Doubek, J. M. Schmidt, and J. J. Rudloe. "Antineoplastic agents 100." Tetrahedron 41, no. 6 (January 1985): 985–94. http://dx.doi.org/10.1016/s0040-4020(01)96466-x.
Bukowski, Ronald M. "Novel antineoplastic agents." Current Oncology Reports 2, no. 1 (January 2000): 9–10. http://dx.doi.org/10.1007/s11912-000-0004-1.
Hong, Samuel J., Edward C. Li, Linda M. Matusiak, and Glen T. Schumock. "Spending on Antineoplastic Agents in the United States, 2011 to 2016." Journal of Oncology Practice 14, no. 11 (November 2018): e683-e691. http://dx.doi.org/10.1200/jop.18.00069.
DOLL, DONALD C., Q. SCOT RINGENBERG, and JOHN W. YARBRO. "Antineoplastic Agents and Pregnancy." Obstetrical & Gynecological Survey 45, no. 6 (June 1990): 376. http://dx.doi.org/10.1097/00006254-199006000-00008.
Pettit, George R., Noeleen Melody, and Jean-Charles Chapuis. "Antineoplastic Agents. 605. Isoquinstatins." Journal of Natural Products 81, no. 3 (September 19, 2017): 451–57. http://dx.doi.org/10.1021/acs.jnatprod.7b00352.
Hussain, M. A. ha, A. N. toinette J. Wozniak, and M. A. rk B. Edelstein. "Neurotoxicity of antineoplastic agents." Critical Reviews in Oncology/Hematology 14, no. 1 (February 1993): 61–75. http://dx.doi.org/10.1016/1040-8428(93)90006-p.
Castells, M. "Hypersensitivity to Antineoplastic Agents." Current Pharmaceutical Design 14, no. 27 (September 1, 2008): 2892–901. http://dx.doi.org/10.2174/138161208786369803.
Fernandez, F. "Psychotoxicity from antineoplastic agents." Journal of Clinical Oncology 5, no. 2 (February 1987): 319–20. http://dx.doi.org/10.1200/jco.1987.5.2.319.
Yamashiro, Yoshiko, Yoshikazu Fukuoka, Akira Yotsuji, Takashi Yasuda, Isamu Saikawa, and Yasushi Ueda. "Interactions of antimicrobial agents and antineoplastic agents." Journal of Antimicrobial Chemotherapy 18, no. 6 (1986): 703–8. http://dx.doi.org/10.1093/jac/18.6.703.
Melamed, Andra J., and Michael L. Kleinberg. "Handling Considerations for Cancer Chemotherapeutic Agents." Drug Intelligence & Clinical Pharmacy 22, no. 3 (March 1988): 247–51. http://dx.doi.org/10.1177/106002808802200317.
Garcia, Gwenalyn, and Jean Paul Atallah. "Antineoplastic agents and thrombotic microangiopathy." Journal of Oncology Pharmacy Practice 23, no. 2 (June 23, 2016): 135–42. http://dx.doi.org/10.1177/1078155216628324.
Sutton, Karen, Tara B. Sanft, Tish M. Knobf, and Izuchukwu K. Ibe. "Musculoskeletal Effects of Antineoplastic Agents." Journal of the American Academy of Orthopaedic Surgeons 27, no. 22 (November 2019): 834–39. http://dx.doi.org/10.5435/jaaos-d-17-00713.
PATTERSON, WILLIAM B. "Occupational Hazard from Antineoplastic Agents." Annals of Internal Medicine 103, no. 6_Part_1 (December 1, 1985): 965. http://dx.doi.org/10.7326/0003-4819-103-6-965_2.
Graeve, Catherine Utecht, Patricia Marie McGovern, Bruce Alexander, Timothy Church, Andrew Ryan, and Martha Polovich. "Occupational Exposure to Antineoplastic Agents." Workplace Health & Safety 65, no. 1 (October 7, 2016): 9–20. http://dx.doi.org/10.1177/2165079916662660.
Bozkurt, Kürşat A., Burak Uzel, Canan Akman, Mustafa Özgüroğlu, and Nil Molinas Mandel. "Intrathoracic Extravasation of Antineoplastic Agents." American Journal of Clinical Oncology 26, no. 2 (April 2003): 121–23. http://dx.doi.org/10.1097/00000421-200304000-00003.
Shahab, Nasir, Syed Haider, and Donald C. Doll. "Vascular Toxicity of Antineoplastic Agents." Seminars in Oncology 33, no. 1 (February 2006): 121–38. http://dx.doi.org/10.1053/j.seminoncol.2005.11.006.
Fortner, Clarence L., and Paul J. Vilk. "Aspects of Investigational Antineoplastic Agents." Journal of Pharmacy Practice 4, no. 1 (February 1991): 64–71. http://dx.doi.org/10.1177/089719009100400107.
Chitambar, Christopher R. "Gallium compounds as antineoplastic agents." Current Opinion in Oncology 16, no. 6 (November 2004): 547–52. http://dx.doi.org/10.1097/01.cco.0000142071.22226.d2.
Hamnvik, O. P. R., P. R. Larsen, and E. Marqusee. "Thyroid Dysfunction from Antineoplastic Agents." JNCI Journal of the National Cancer Institute 103, no. 21 (October 18, 2011): 1572–87. http://dx.doi.org/10.1093/jnci/djr373.
Grangé, Steven, and Paul Coppo. "Thrombotic microangiopathies and antineoplastic agents." Néphrologie & Thérapeutique 13 (April 2017): S109—S113. http://dx.doi.org/10.1016/j.nephro.2017.01.016.
Pettit, George R., Noeleen Melody, and Jean-Charles Chapuis. "Antineoplastic Agents. 606. The Betulastatins." Journal of Natural Products 81, no. 3 (January 5, 2018): 458–64. http://dx.doi.org/10.1021/acs.jnatprod.7b00536.
Pettit, George R., Noeleen Melody, and Jean-Charles Chapuis. "Antineoplastic Agents. 607. Emetine Auristatins." Journal of Natural Products 83, no. 5 (April 23, 2020): 1571–76. http://dx.doi.org/10.1021/acs.jnatprod.0c00031.
Pettit, G. R., S. B. Singh, A. Goswami, and R. A. Nieman. "Antineoplastic agents 157. Quassia kerstingII1." Tetrahedron 44, no. 11 (January 1988): 3349–54. http://dx.doi.org/10.1016/s0040-4020(01)85969-x.
Pettit, George R., Venkatswamy Gaddamidi, Delbert L. Herald, Sheo Bux Singh, Gordon M. Cragg, Jean M. Schmidt, Fred E. Boettner, M. Williams, and Yoneo Sagawa. "Antineoplastic Agents, 120. Pancratium littorale." Journal of Natural Products 49, no. 6 (November 1986): 995–1002. http://dx.doi.org/10.1021/np50048a005.
Pettit, George R., Gordon M. Cragg, Sheo Bux Singh, James A. Duke, and Dennis L. Doubek. "Antineoplastic Agents, 162. Zephyranthes candida." Journal of Natural Products 53, no. 1 (January 1990): 176–78. http://dx.doi.org/10.1021/np50067a026.
Rogers, Bonnie. "Antineoplastic Agents Action and Toxicities." AAOHN Journal 34, no. 11 (November 1986): 530–38. http://dx.doi.org/10.1177/216507998603401104.
Bodet, C. A., J. H. Jorgensen, and D. J. Drutz. "Antibacterial activities of antineoplastic agents." Antimicrobial Agents and Chemotherapy 28, no. 3 (September 1, 1985): 437–39. http://dx.doi.org/10.1128/aac.28.3.437.
Pettit, George R., Noeleen Melody, Michael Simpson, Michael Thompson, Delbert L. Herald, and John C. Knight. "Antineoplastic Agents 500. Narcistatin†,1." Journal of Natural Products 66, no. 1 (January 2003): 92–96. http://dx.doi.org/10.1021/np020225i.
Bozkurt, Kürşat A., Burak Uzel, Canan Akman, Mustafa Özgüroğlu, and Nil Molinas Mandel. "Intrathoracic Extravasation of Antineoplastic Agents." American Journal of Clinical Oncology 26, no. 2 (April 2003): 121–23. http://dx.doi.org/10.1097/01.coc.0000017088.74592.96.
Weiss, Raymond B., and James R. Baker. "Hypersensitivity reactions from antineoplastic agents." Cancer and Metastasis Reviews 6, no. 3 (November 1987): 413–32. http://dx.doi.org/10.1007/bf00144273.
Borch, Richard F., and Thomas J. Montine. "Renal toxicity of antineoplastic agents." Toxicology Letters 53, no. 1-2 (September 1990): 93–96. http://dx.doi.org/10.1016/0378-4274(90)90100-z.
Johnson, Candace S. "Modulation of chemotherapy antineoplastic agents with biologic agents." Current Opinion in Oncology 4, no. 6 (December 1992): 1108. http://dx.doi.org/10.1097/00001622-199212000-00016.
Hall, Amy L., Paul A. Demers, George Astrakianakis, Calvin Ge, and Cheryl E. Peters. "Estimating National-Level Exposure to Antineoplastic Agents in the Workplace: CAREX Canada Findings and Future Research Needs." Annals of Work Exposures and Health 61, no. 6 (June 8, 2017): 656–58. http://dx.doi.org/10.1093/annweh/wxx042.
&NA;. "Antineoplastic agents can cause allergic reactions." Reactions Weekly &NA;, no. 428 (November 1992): 4. http://dx.doi.org/10.2165/00128415-199204280-00008.
&NA;. "Pharmacokinetic drug interactions with antineoplastic agents." Drugs & Therapy Perspectives 5, no. 9 (May 1995): 12–14. http://dx.doi.org/10.2165/00042310-199505090-00005.
BATRA, JANENDRA K., CHII M. LIN, ERNEST HAMEL, LEONARD JURD, and LARRY J. POWERS. "New Antineoplastic Agents with Antitubulin Activity." Annals of the New York Academy of Sciences 466, no. 1 Dynamic Aspec (June 1986): 785–87. http://dx.doi.org/10.1111/j.1749-6632.1986.tb38459.x.
McDiarmid, Melissa, and Thomas Egan. "Acute Occupational Exposure to Antineoplastic Agents." Journal of Occupational and Environmental Medicine 30, no. 12 (December 1988): 984–87. http://dx.doi.org/10.1097/00043764-198812000-00020.
Dimopoulou, I., A. Bamias, P. Lyberopoulos, and M. A. Dimopoulos. "Pulmonary toxicity from novel antineoplastic agents." Annals of Oncology 17, no. 3 (March 2006): 372–79. http://dx.doi.org/10.1093/annonc/mdj057.
Delitheos, A., I. Karavokyros, and E. Tiligada. "Response ofSaccharomyces cerevisiaestrains to antineoplastic agents." Journal of Applied Bacteriology 79, no. 4 (October 1995): 379–83. http://dx.doi.org/10.1111/j.1365-2672.1995.tb03151.x.
Phillips, Nancy C. "The Safe Handling of Antineoplastic Agents." Journal of Pharmacy Technology 1, no. 1 (January 1985): 19–24. http://dx.doi.org/10.1177/875512258500100108.
Davis, Lisa E. "Long-Term Complications of Antineoplastic Agents." Journal of Pharmacy Practice 4, no. 2 (April 1991): 131–50. http://dx.doi.org/10.1177/089719009100400208.
Hercbergs, A. A., D. Garfield, O. Ashur-Fabian, and P. J. Davis. "Re: Thyroid Dysfunction from Antineoplastic Agents." JNCI Journal of the National Cancer Institute 104, no. 5 (January 30, 2012): 422–23. http://dx.doi.org/10.1093/jnci/djs011.
P. Torchilin, Vladimir, Leonid Z. Iakoubov, and Zeev Estrov. "Antinuclear autoantibodies as potential antineoplastic agents." Trends in Immunology 22, no. 8 (August 2001): 424–27. http://dx.doi.org/10.1016/s1471-4906(01)01984-6.
Wiebe, Valerie J., and Pirkko E. H. Sipila. "Pharmacology of antineoplastic agents in pregnancy." Critical Reviews in Oncology/Hematology 16, no. 2 (April 1994): 75–112. http://dx.doi.org/10.1016/1040-8428(94)90043-4.
Markman, Maurie. "Toxicities of the platinum antineoplastic agents." Expert Opinion on Drug Safety 2, no. 6 (November 2003): 597–607. http://dx.doi.org/10.1517/14740338.2.6.597.
Polovich, Martha. "Minimizing Occupational Exposure to Antineoplastic Agents." Journal of Infusion Nursing 39, no. 5 (2016): 307–13. http://dx.doi.org/10.1097/nan.0000000000000183.
Lazo, John S. "Endothelial injury caused by antineoplastic agents." Biochemical Pharmacology 35, no. 12 (June 1986): 1919–23. http://dx.doi.org/10.1016/0006-2952(86)90720-3.